The store will not work correctly when cookies are disabled.
4-(bis(2-methoxyethyl)amino)-7H-pyrido[4,3,2-de][1,7]phenanthrolin-7-one
ID: ALA3347687
PubChem CID: 10473946
Max Phase: Preclinical
Molecular Formula: C20H20N4O3
Molecular Weight: 364.41
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COCCN(CCOC)c1cnc2c3c(nccc13)-c1cccnc1C2=O
Standard InChI: InChI=1S/C20H20N4O3/c1-26-10-8-24(9-11-27-2)15-12-23-19-16-13(15)5-7-22-17(16)14-4-3-6-21-18(14)20(19)25/h3-7,12H,8-11H2,1-2H3
Standard InChI Key: LTTYTBNHKUPCMG-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
8.7710 -22.2019 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7699 -23.0290 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4845 -23.4418 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.4826 -21.7892 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1979 -22.1982 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1967 -23.0264 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9094 -23.4393 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6274 -23.0248 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3396 -23.4368 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.0538 -23.0253 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0515 -22.1975 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9118 -21.7828 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6280 -22.2016 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3467 -21.7908 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9136 -20.9577 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.9088 -24.2641 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.6293 -20.5444 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3470 -20.9621 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7651 -21.7841 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.4800 -22.1955 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7639 -20.9594 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4777 -20.5460 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4765 -19.7212 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.1901 -19.3078 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4812 -23.0202 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1961 -23.4316 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.1973 -24.2563 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
5 12 1 0
6 7 1 0
7 8 1 0
13 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 14 2 0
12 13 1 0
13 14 1 0
14 18 1 0
17 15 1 0
15 12 2 0
7 16 2 0
17 18 2 0
11 19 1 0
19 20 1 0
19 21 1 0
21 22 1 0
22 23 1 0
23 24 1 0
20 25 1 0
25 26 1 0
26 27 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 364.41 | Molecular Weight (Monoisotopic): 364.1535 | AlogP: 2.34 | #Rotatable Bonds: 7 |
Polar Surface Area: 77.44 | Molecular Species: NEUTRAL | HBA: 7 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 2.54 | CX LogP: 1.61 | CX LogD: 1.61 |
Aromatic Rings: 3 | Heavy Atoms: 27 | QED Weighted: 0.50 | Np Likeness Score: -0.07 |
References
1. Chen JL, Sperry J, Ip NY, Brimble MA. (2011) Natural products targeting telomere maintenance, 2 (4): [10.1039/C0MD00241K] |